Tumstatin, type IV collagen-derived endogenous angiogenesis inhibitor, is defined as the 28 kDanoncollagenous domain (indicated as α3(IV)NC) and has been shown to suppress tumor progress in various mouse cancer models23. Here, COL4A3 is linked to neoplasm.